Literature DB >> 33925132

The Effect and Regulatory Mechanism of High Mobility Group Box-1 Protein on Immune Cells in Inflammatory Diseases.

Yun Ge1, Man Huang1, Yong-Ming Yao1,2.   

Abstract

High mobility group box-1 protein (HMGB1), a member of the high mobility group protein superfamily, is an abundant and ubiquitously expressed nuclear protein. Intracellular HMGB1 is released by immune and necrotic cells and secreted HMGB1 activates a range of immune cells, contributing to the excessive release of inflammatory cytokines and promoting processes such as cell migration and adhesion. Moreover, HMGB1 is a typical damage-associated molecular pattern molecule that participates in various inflammatory and immune responses. In these ways, it plays a critical role in the pathophysiology of inflammatory diseases. Herein, we review the effects of HMGB1 on various immune cell types and describe the molecular mechanisms by which it contributes to the development of inflammatory disorders. Finally, we address the therapeutic potential of targeting HMGB1.

Entities:  

Keywords:  damage-associated molecular pattern; high mobility group box-1 protein; immune cells; inflammatory disorders

Year:  2021        PMID: 33925132     DOI: 10.3390/cells10051044

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  231 in total

Review 1.  HMGB proteins: interactions with DNA and chromatin.

Authors:  Michal Stros
Journal:  Biochim Biophys Acta       Date:  2010 Jan-Feb

2.  Serum levels of HMGB1 in postmenopausal patients with rheumatoid arthritis: associations with proinflammatory cytokines, acute-phase reactants, and clinical disease characteristics.

Authors:  Rille Pullerits; Vilma Urbonaviciute; Reinhard E Voll; Helena Forsblad-D'Elia; Hans Carlsten
Journal:  J Rheumatol       Date:  2011-07       Impact factor: 4.666

3.  Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 Axis.

Authors:  Yuhei Irie; Maho Tsubota; Hiroyasu Ishikura; Fumiko Sekiguchi; Yuka Terada; Toshifumi Tsujiuchi; Keyue Liu; Masahiro Nishibori; Atsufumi Kawabata
Journal:  J Neuroimmune Pharmacol       Date:  2017-07-28       Impact factor: 4.147

4.  Impaired efferocytosis and neutrophil extracellular trap clearance by macrophages in ARDS.

Authors:  Murielle Grégoire; Fabrice Uhel; Mathieu Lesouhaitier; Arnaud Gacouin; Marion Guirriec; Frederic Mourcin; Erwan Dumontet; Arnaud Chalin; Michel Samson; Laure-Line Berthelot; Adrien Tissot; Mallorie Kerjouan; Stéphane Jouneau; Yves Le Tulzo; Karin Tarte; Jaroslaw W Zmijewski; Jean-Marc Tadié
Journal:  Eur Respir J       Date:  2018-08-02       Impact factor: 16.671

5.  HMGB1 mediates cognitive impairment in sepsis survivors.

Authors:  Sangeeta S Chavan; Patricio T Huerta; Sergio Robbiati; S I Valdes-Ferrer; Mahendar Ochani; Meghan Dancho; Maya Frankfurt; Bruce T Volpe; Kevin J Tracey; Betty Diamond
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

6.  TLR activation regulates damage-associated molecular pattern isoforms released during pyroptosis.

Authors:  Sanna Nyström; Daniel J Antoine; Peter Lundbäck; John G Lock; Andreia F Nita; Kari Högstrand; Alf Grandien; Helena Erlandsson-Harris; Ulf Andersson; Steven E Applequist
Journal:  EMBO J       Date:  2012-12-07       Impact factor: 11.598

7.  Cholinergic anti-inflammatory pathway activity and High Mobility Group Box-1 (HMGB1) serum levels in patients with rheumatoid arthritis.

Authors:  Richard S Goldstein; Annette Bruchfeld; Lihong Yang; Abdul R Qureshi; Margot Gallowitsch-Puerta; Nirav B Patel; Brett J Huston; Sangeeta Chavan; Mauricio Rosas-Ballina; Peter K Gregersen; Christopher J Czura; Richard P Sloan; Andrew E Sama; Kevin J Tracey
Journal:  Mol Med       Date:  2007 Mar-Apr       Impact factor: 6.354

8.  HMGB1 is upregulated in the airways in asthma and potentiates airway smooth muscle contraction via TLR4.

Authors:  Leonarda Di Candia; Edith Gomez; Emilie Venereau; Latifa Chachi; Davinder Kaur; Marco E Bianchi; R A John Challiss; Christopher E Brightling; Ruth M Saunders
Journal:  J Allergy Clin Immunol       Date:  2017-03-01       Impact factor: 10.793

9.  RAGE is a nucleic acid receptor that promotes inflammatory responses to DNA.

Authors:  Cherilyn M Sirois; Tengchuan Jin; Allison L Miller; Damien Bertheloot; Hirotaka Nakamura; Gabor L Horvath; Abubakar Mian; Jiansheng Jiang; Jacob Schrum; Lukas Bossaller; Karin Pelka; Natalio Garbi; Yambasu Brewah; Jane Tian; ChewShun Chang; Partha S Chowdhury; Gary P Sims; Roland Kolbeck; Anthony J Coyle; Alison A Humbles; T Sam Xiao; Eicke Latz
Journal:  J Exp Med       Date:  2013-09-30       Impact factor: 14.307

10.  HMGB1-triggered inflammation inhibition of notoginseng leaf triterpenes against cerebral ischemia and reperfusion injury via MAPK and NF-κB signaling pathways.

Authors:  Weijie Xie; Ting Zhu; Xi Dong; Fengwei Nan; Xiangbao Meng; Ping Zhou; Guibo Sun; Xiaobo Sun
Journal:  Biomolecules       Date:  2019-09-20
View more
  9 in total

Review 1.  Unboxing the molecular modalities of mutagens in cancer.

Authors:  Smita Kumari; Sudhanshu Sharma; Dia Advani; Akanksha Khosla; Pravir Kumar; Rashmi K Ambasta
Journal:  Environ Sci Pollut Res Int       Date:  2021-10-05       Impact factor: 5.190

Review 2.  Complement System and Alarmin HMGB1 Crosstalk: For Better or Worse.

Authors:  Christine Gaboriaud; Marie Lorvellec; Véronique Rossi; Chantal Dumestre-Pérard; Nicole M Thielens
Journal:  Front Immunol       Date:  2022-04-28       Impact factor: 8.786

Review 3.  Endogenous Regulation and Pharmacological Modulation of Sepsis-Induced HMGB1 Release and Action: An Updated Review.

Authors:  Cassie Shu Zhu; Wei Wang; Xiaoling Qiang; Weiqiang Chen; Xiqian Lan; Jianhua Li; Haichao Wang
Journal:  Cells       Date:  2021-08-27       Impact factor: 6.600

Review 4.  High-Mobility Group Box-1 and Its Potential Role in Perioperative Neurocognitive Disorders.

Authors:  Sarah Saxena; Véronique Kruys; Raf De Jongh; Joseph Vamecq; Mervyn Maze
Journal:  Cells       Date:  2021-09-28       Impact factor: 6.600

Review 5.  Ferroptosis-Mediated Formation of Tumor-Promoting Immune Microenvironment.

Authors:  Qing Bi; Ze-Jia Sun; Ji-Yue Wu; Wei Wang
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244

Review 6.  The Role of HMGB1 in Rheumatic Diseases.

Authors:  Yuanji Dong; Bingxia Ming; Lingli Dong
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

Review 7.  An Update on the Pathogenic Role of Neutrophils in Systemic Juvenile Idiopathic Arthritis and Adult-Onset Still's Disease.

Authors:  Ji-Won Kim; Mi-Hyun Ahn; Ju-Yang Jung; Chang-Hee Suh; Hyoun-Ah Kim
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

8.  A microsatellite DNA-derived oligodeoxynucleotide attenuates lipopolysaccharide-induced acute lung injury in mice by inhibiting the HMGB1-TLR4-NF-κB signaling pathway.

Authors:  Chenghua Zhang; Hui Wang; Hongrui Wang; Shuyou Shi; Peiyan Zhao; Yingying Su; Hua Wang; Ming Yang; Mingli Fang
Journal:  Front Microbiol       Date:  2022-08-04       Impact factor: 6.064

9.  HMGB1 Inhibition to Ameliorate Organ Failure and Increase Survival in Trauma.

Authors:  Zhangsheng Yang; Milomir O Simovic; Peter R Edsall; Bin Liu; Tomas S Cancio; Andriy I Batchinsky; Leopoldo C Cancio; Yansong Li
Journal:  Biomolecules       Date:  2022-01-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.